Correction: Development and in vitro and ex vivo characterization of a twin nanoparticulate system to enhance ocular absorption and prolong retention of dexamethasone in the eye: from lab to pilot scale optimization

Muhammad Sarfraz; Gautam Behl; Sweta Rani; Niall O'Reilly; Peter McLoughlin; Orla O'Donovan; Alison L. Reynolds; John Lynch; Laurence Fitzhenry

doi:10.1039/D5NA90032H

You do not have JavaScript enabled. Please enable JavaScript to access the full features of the site or access our non-JavaScript page.

Correction: Development and in vitro and ex vivo characterization of a twin nanoparticulate system to enhance ocular absorption and prolong retention of dexamethasone in the eye: from lab to pilot scale optimization

Muhammad Sarfraz,*^ab Gautam Behl,^a Sweta Rani,^a Niall O'Reilly,^a Peter McLoughlin,^a Orla O'Donovan,^a Alison L. Reynolds,^cd John Lynch^a and Laurence Fitzhenry*^a

Author affiliations

* Corresponding authors

^a Ocular Therapeutics Research Group (OTRG), Pharmaceutical & Molecular Biotechnology Research Centre (PMBRC), South East Technological University, Waterford X91 KOEK, Waterford, Ireland
E-mail: muhammad.sarfraz@setu.ie

^b Faculty of Pharmacy, The University of Lahore, Lahore 56400, Pakistan

^c UCD School of Veterinary Medicine, Dublin, Ireland

^d UCD Conway Institute of Biomolecular and Biomedical Research, University College Dublin (UCD), Dublin D04 V1W8, Ireland

Abstract

Correction for ‘Development and in vitro and ex vivo characterization of a twin nanoparticulate system to enhance ocular absorption and prolong retention of dexamethasone in the eye: from lab to pilot scale optimization’ by Muhammad Sarfraz et al., Nanoscale Adv., 2025, https://doi.org/10.1039/d4na01086h.

Download options Please wait...

Associated articles

Development and in vitro and ex vivo characterization of a twin nanoparticulate …

Article information

DOI: https://doi.org/10.1039/D5NA90032H
Article type: Correction
Submitted: 24 Apr 2025
Accepted: 24 Apr 2025
First published: 02 May 2025
This article is Open Access

Download Citation

Nanoscale Adv., 2025,7, 3143-3143

Permissions

Request permissions

Correction: Development and in vitro and ex vivo characterization of a twin nanoparticulate system to enhance ocular absorption and prolong retention of dexamethasone in the eye: from lab to pilot scale optimization

M. Sarfraz, G. Behl, S. Rani, N. O'Reilly, P. McLoughlin, O. O'Donovan, A. L. Reynolds, J. Lynch and L. Fitzhenry, Nanoscale Adv., 2025, 7, 3143 DOI: 10.1039/D5NA90032H

This article is licensed under a Creative Commons Attribution 3.0 Unported Licence. You can use material from this article in other publications without requesting further permissions from the RSC, provided that the correct acknowledgement is given.

Social activity

Fetching data from CrossRef.
This may take some time to load.

Nanoscale Advances

Correction: Development and in vitro and ex vivo characterization of a twin nanoparticulate system to enhance ocular absorption and prolong retention of dexamethasone in the eye: from lab to pilot scale optimization

Abstract

Associated articles

Article information

Download Citation

Permissions

Correction: Development and in vitro and ex vivo characterization of a twin nanoparticulate system to enhance ocular absorption and prolong retention of dexamethasone in the eye: from lab to pilot scale optimization

Social activity

Search articles by author

Spotlight

Advertisements